RIPK1 and Alzheimer disease: In AD, TNF-α levels are significantly elevated, activating the RIPK1-RIPK3-MLKL pathway, which leads to cell membrane damage, neuronal necroptosis, and intensified neuroinflammation (Kim et al., 2025).